{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-088393","form_type":"8-K","ticker":"NNVC","cik":"0001379006","company_name":"NANOVIRICIDES, INC.","filed_at":"2026-07-30T10:02:18+00:00","discovered_at":"2026-07-30T10:10:00.309593+00:00","generated_at":"2026-07-30T10:10:53.263084+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"NanoViricides raises ~$3.8M in registered direct offering of common stock and warrants","bullets":["Gross proceeds of ~$3.8M from sale of 2,516,339 shares (or pre-funded warrants) and warrants to purchase 2,516,339 shares at $1.75.","Offering closed on July 27, 2026; net proceeds for working capital, R&D, clinical trials, and strategic purposes.","CEO and principal stockholder TheraCour Pharma entered 30-day lock-up agreements restricting share sales.","D. Boral Capital acted as exclusive placement agent with 7.0% cash fee and up to $50,000 expense reimbursement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-088393","json":"https://secwatch.observer/filing/0001104659-26-088393.json","markdown":"https://secwatch.observer/filing/0001104659-26-088393.md","text":"https://secwatch.observer/filing/0001104659-26-088393.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1379006/000110465926088393/0001104659-26-088393-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1379006/000110465926088393/tm2621493d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-30T10:10:53.263084+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}